LINCOCIN Side Effects

6992059-2 | Hypoaesthesia
on Sep 08, 2010 Male patient from JAPAN , 63 years of age, was diagnosed with acute tonsillitis and was treated with Lincocin (View Usage). Patient experienced the following unwanted or unexpected effects: hypoaesthesia. Lincocin dosage: 600 Mg, Unk. During the same period patient was treated with SALICYLAMIDE (3 G, Unk) (View Salicylamide Review and Salicylamide Label ), MEDICON (90 Mg, Unk) (View Medicon Review and Medicon Label ), CEFZON (300 Mg, Unk) (View Cefzon Review and Cefzon Label ), TANATRIL ^ALGOL^ (5 Mg, Unk) (View Tanatril ^algol^ Review and Tanatril ^algol^ Label ), ASPIRIN (100 Mg, Unk) (View Aspirin Review and Aspirin Label ), SITAGLIPTIN PHOSPHATE (50 Mg, Unk) (View Sitagliptin Phosphate Review and Sitagliptin Phosphate Label ), HERBESSER ^DELTA^ (60 Mg, Unk) (View Herbesser ^delta^ Review and Herbesser ^delta^ Label ), PERSANTIN (75 Mg, Unk) (View Persantin Review and Persantin Label ).

6920948-3 | Angioedema, Urticaria
Patient was taking Lincocin (View Usage). Patient had the following side effects: angioedema, urticaria on Aug 02, 2010 from ITALY Additional patient health information: Female patient , 48 years of age, . Lincocin dosage: Unk. Patient was hospitalized.

6895407-7 | Hypoaesthesia
Adverse event was reported on Jul 22, 2010 by a Male patient taking Lincocin (View Usage) (Dosage: 600 Mg, Unk) was diagnosed with acute tonsillitis and. Location: JAPAN , 63 years of age, After Lincocin was administered, patient had the following side effects: hypoaesthesia. During the same period patient was treated with SALICYLAMIDE (3 G, Unk) (View Salicylamide Review and Salicylamide Label ), MEDICON (90 Mg, Unk) (View Medicon Review and Medicon Label ), CEFZON (300 Mg, Unk) (View Cefzon Review and Cefzon Label ), TANATRIL ^ALGOL^ (5 Mg, Unk) (View Tanatril ^algol^ Review and Tanatril ^algol^ Label ), ASPIRIN (100 Mg, Unk) (View Aspirin Review and Aspirin Label ), SITAGLIPTIN PHOSPHATE (50 Mg, Unk) (View Sitagliptin Phosphate Review and Sitagliptin Phosphate Label ), HERBESSER ^DELTA^ (60 Mg, Unk) (View Herbesser ^delta^ Review and Herbesser ^delta^ Label ), PERSANTINE (75 Mg, Unk) (View Persantine Review and Persantine Label ).

6878175-4 | Oedema Mouth, Paraesthesia, Tachycardia, Visual Acuity Reduced
on Jul 15, 2010 Female patient from ITALY , 48 years of age, was diagnosed with infection (What is infection?) and was treated with Lincocin (View Usage). Patient experienced the following unwanted or unexpected effects: oedema mouth, paraesthesia, tachycardia, visual acuity reduced. Lincocin dosage: 1 Unit, Total. Patient was hospitalized.


6831282-4 | Hypoaesthesia
on Jul 01, 2010 Male patient from JAPAN , 63 years of age, was diagnosed with acute tonsillitis and was treated with Lincocin (View Usage). Patient had the following side effects: hypoaesthesia. Lincocin dosage: 600 Mg, Unk. During the same period patient was treated with SALICYLAMIDE (3 G, Unk) (View Salicylamide Review and Salicylamide Label ), MEDICON (90 Mg, Unk) (View Medicon Review and Medicon Label ), CEFZON (300 Mg, Unk) (View Cefzon Review and Cefzon Label ), TANATRIL ^ALGOL^ (5 Mg, Unk) (View Tanatril ^algol^ Review and Tanatril ^algol^ Label ), ASPIRIN (100 Mg, Unk) (View Aspirin Review and Aspirin Label ), SITAGLIPTIN PHOSPHATE (50 Mg, Unk) (View Sitagliptin Phosphate Review and Sitagliptin Phosphate Label ), HERBESSER ^DELTA^ (60 Mg, Unk) (View Herbesser ^delta^ Review and Herbesser ^delta^ Label ), PERSANTINE (75 Mg, Unk) (View Persantine Review and Persantine Label ).

6792357-1 | Dizziness, Thinking Abnormal
Patient was taking Lincocin (View Usage). After Lincocin was administered, patient had the following side effects: dizziness (What is dizziness?), thinking abnormal on Oct 20, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 150.0 lb, was diagnosed with nasopharyngitis, bronchitis (What is bronchitis?) and. Lincocin dosage: .

6755378-0 | Oedema, Paraesthesia, Tachycardia
Adverse event was reported on May 24, 2010 by a Female patient taking Lincocin (View Usage) (Dosage: 1 Unit, Total) was diagnosed with infection (What is infection?) and. Location: ITALY , 48 years of age, Patient experienced the following unwanted or unexpected effects: oedema, paraesthesia, tachycardia. Patient was hospitalized.

5808042-6 | Inflammation
on Jul 01, 2008 Male patient from POLAND , weighting 72.75 lb, was treated with Lincocin (View Usage). Patient had the following side effects: inflammation. Lincocin dosage: Daily Dose:600mg. During the same period patient was treated with VIRLIX (View Virlix Review and Virlix Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ).

5573824-5 | Electrocardiogram Qt Prolonged
on Dec 18, 2007 Male patient from JAPAN , 70 years of age, was treated with Lincocin (View Usage). After Lincocin was administered, patient had the following side effects: electrocardiogram qt prolonged. Lincocin dosage: Text:2 Vial.

5529625-7 | Electrocardiogram Qt Prolonged
Patient was taking Lincocin (View Usage). Patient experienced the following unwanted or unexpected effects: electrocardiogram qt prolonged on Nov 19, 2007 from JAPAN Additional patient health information: Male patient , 70 years of age, . Lincocin dosage: Text:2 Vial.

5524355-X | Electrocardiogram Qt Prolonged
Adverse event was reported on Nov 12, 2007 by a Male patient taking Lincocin (View Usage) (Dosage: Text:2 Vial) . Location: JAPAN , 79 years of age, Patient had the following side effects: electrocardiogram qt prolonged.

5317234-4 | Limb Discomfort, Movement Disorder, Pain
on Apr 23, 2007 Female patient from UNITED STATES , weighting 155.0 lb, was diagnosed with sinusitis (What is sinusitis?), sinus congestion, lacrimation increased and was treated with Lincocin (View Usage). After Lincocin was administered, patient had the following side effects: limb discomfort, movement disorder (What is movement disorder?), pain (What is pain?). Lincocin dosage: . During the same period patient was treated with CELESTONE (View Celestone Review and Celestone Label ), NASONEX (View Nasonex Review and Nasonex Label ).

5283999-3 | Stevens-johnson Syndrome
on Mar 21, 2007 Male patient from PAKISTAN , 25 years of age, weighting 154.3 lb, was diagnosed with otitis media chronic and was treated with Lincocin (View Usage). Patient experienced the following unwanted or unexpected effects: stevens-johnson syndrome. Lincocin dosage: . During the same period patient was treated with ERYTHROMYCIN (View Erythromycin Review and Erythromycin Label ), CLEMASTINE FUMARATE (View Clemastine Fumarate Review and Clemastine Fumarate Label ).

5270238-2 | Stevens-johnson Syndrome
Patient was taking Lincocin (View Usage). Patient had the following side effects: stevens-johnson syndrome on Mar 08, 2007 from PAKISTAN Additional patient health information: Male patient , 25 years of age, weighting 154.3 lb, was diagnosed with otitis media chronic and. Lincocin dosage: . During the same period patient was treated with ERYTHROMYCIN (Daily Dose:1000mg) (View Erythromycin Review and Erythromycin Label ).

4862963-X | Liver Disorder, Obliterative Bronchiolitis, Obstructive Airways Disorder, Toxic Epidermal Necrolysis
Adverse event was reported on Dec 05, 2005 by a Male patient taking Lincocin (View Usage) (Dosage: 600 Mg Intravenous) was diagnosed with ill-defined disorder and. Location: JAPAN , 33 years of age, After Lincocin was administered, patient had the following side effects: liver disorder, obliterative bronchiolitis, obstructive airways disorder, toxic epidermal necrolysis. During the same period patient was treated with CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ), CALONAL (PARACETAMOL) (View Calonal (paracetamol) Review and Calonal (paracetamol) Label ).

4823335-7 | Depressed Level Of Consciousness, Dysphagia, Hypoxic Encephalopathy, Laryngeal Oedema, Respiratory Arrest
on Oct 26, 2005 Male patient from JAPAN , 47 years of age, was diagnosed with pharyngeal erythema, pharyngeal oedema and was treated with Lincocin (View Usage). Patient experienced the following unwanted or unexpected effects: depressed level of consciousness, dysphagia, hypoxic encephalopathy, laryngeal oedema, respiratory arrest. Lincocin dosage: 600 Mg, Intravenous. During the same period patient was treated with PABRON (CAFFEINE, CARBINOXAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE (View Pabron (caffeine, Carbinoxamine Maleate, Dextromethorphan Hydrobromide Review and Pabron (caffeine, Carbinoxamine Maleate, Dextromethorphan Hydrobromide Label ). Patient was hospitalized and became disabled.

4810410-6 | Depressed Level Of Consciousness, Dysphagia, Dyspnoea, Laryngeal Oedema, Respiratory Arrest
on Oct 12, 2005 Male patient from JAPAN , 47 years of age, was diagnosed with pharyngeal oedema and was treated with Lincocin (View Usage). Patient had the following side effects: depressed level of consciousness, dysphagia, dyspnoea, laryngeal oedema, respiratory arrest. Lincocin dosage: Intravenous. During the same period patient was treated with PARBON (SEE IMAGE) (View Parbon (see Image) Review and Parbon (see Image) Label ). Patient was hospitalized.

4809927-X | Dysphagia, Dyspnoea, Laryngeal Oedema, Loss Of Consciousness, Procedural Complication, Respiratory Arrest
Patient was taking Lincocin (View Usage). After Lincocin was administered, patient had the following side effects: dysphagia, dyspnoea, laryngeal oedema, loss of consciousness, procedural complication, respiratory arrest on Oct 12, 2005 from JAPAN Additional patient health information: Male patient , 47 years of age, was diagnosed with pharyngeal oedema and. Lincocin dosage: Intravenous. During the same period patient was treated with PABRON (CAFFEINE, CARBINOXAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE (View Pabron (caffeine, Carbinoxamine Maleate, Dextromethorphan Hydrobromide Review and Pabron (caffeine, Carbinoxamine Maleate, Dextromethorphan Hydrobromide Label ). Patient was hospitalized.

4799696-4 | Laryngeal Oedema, Respiratory Arrest
Adverse event was reported on Sep 27, 2005 by a Male patient taking Lincocin (View Usage) (Dosage: Intravenous) was diagnosed with pharyngeal oedema and. Location: JAPAN , 47 years of age, Patient experienced the following unwanted or unexpected effects: laryngeal oedema, respiratory arrest. During the same period patient was treated with PABRON (CAFFEINE, CARBINOXAMINE MALEATE, DEXTROMETORPHAN HYDROBROMIDE, (View Pabron (caffeine, Carbinoxamine Maleate, Dextrometorphan Hydrobromide, Review and Pabron (caffeine, Carbinoxamine Maleate, Dextrometorphan Hydrobromide, Label ). Patient was hospitalized.